semaglutide approval for weight loss FDA Approves Oral Semaglutide: First GLP-1 Pill US FDA approves weight loss

Call it legal doping for the rest of us

Most patients begin to see consistent weight loss movement at the 5mg dose stage (weeks 5 onward)

Originally developed as a glucagon-like peptide-1 (GLP-1) receptor agonist for diabetes, its versatility has propelled it into a prominent role in the fight against obesity

The 17.2 mg tablet delivers the same dose as the 36 mg capsule used in the trial and produces an average weight loss of 11.1% at the approved dose, essentially matching the trial result

If youre on a potassium-sparing diuretic or an ACE inhibitor, dont add potassium supplements without your prescribers input, as these medications can raise potassium levels too

Non-GMO Dosage and use: Take one (1) capsule once or twice per day on an empty stomach, or as directed by a healthcare practitioner